Collapsing focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus

Case Reports in Medicine

Volumn 2014, Issue , 2014, Pages

  Tariq, Hassan ^a   Rafiq, Arsalan ^a   Franchin, Giovanni ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; HYALIN; HYDROXYCHLOROQUINE; LA ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; RHEUMATOID FACTOR; RO ANTIBODY; STEROID; VANCOMYCIN;

ABNORMAL RESPIRATORY SOUND; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSPNEA; EPITHELIUM CELL; ERYTHROCYTE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMATOCRIT; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FUNCTION; LEUKOCYTE; LEUKOCYTE COUNT; LEUKOCYTOCLASTIC VASCULITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS VULGARIS; METABOLIC ACIDOSIS; NEUTROPHIL; PERICARDIAL EFFUSION; PLEURA EFFUSION; PLEURA FLUID; PLEURISY; PNEUMONIA; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SEROLOGY; SJOEGREN SYNDROME; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREMIA; VASCULITIC RASH;

EID: 84978876368     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2014/732192     Document Type: Article

References (28)

1. Z. Amoura, S. Georgin-Lavialle, J. Haroche et al., "Collapsing glomerulopathy in systemic autoimmune disorders: A case occurring in the course of full blown systemic lupus erythematosus," Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 277-278, 2006.
2. A. Valeri, L. Barisoni, G. B. Appel, R. Seigle, and V. D'Agati, "Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study," Kidney International, vol. 50, no. 5, pp. 1734-1746, 1996.
3. M. Albaqumi, T. J. Soos, L. Barisoni, and P. J. Nelson, "Collapsing glomerulopathy," Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2854-2863, 2006.
4. L. Barisoni, H. W. Schnaper, and J. B. Kopp, "A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases," Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 529-542, 2007.
5. S. P. Salvatore, L. M. C. Barisoni, A. M. Herzenberg, P. N. Chander, V. Nickeleit, and S. V. Seshan, "Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or Lupus-like disease," Clinical Journal of the American Society of Nephrology, vol. 7, no. 6, pp. 914-925, 2012.
6. R. Nasr, C. Johns, and E. Gertner, "Collapsing glomerulopathy in collagen vascular-like disease," Lupus, vol. 23, no. 1, pp. 75-80, 2014.
7. R. K. Detwiler, R. J. Falk, S. L. Hogan, and J. C. Jennette, "Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis," Kidney International, vol. 45, no. 5, pp. 1416-1424, 1994.
8. A. Laurinavicius, S. Hurwitz, and H. G. Rennke, "Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study," Kidney International, vol. 56, no. 6, pp. 2203-2213, 1999.
9. V. D'Agati, J. Suh, L. Carbone, J. Cheng, and G. Appel, "Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study," Kidney International, vol. 35, no. 6, pp. 1358-1370, 1989.
10. C. M. Wyatt, P. E. Klotman, and V. D. D'Agati, "HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy," Seminars in Nephrology, vol. 28, no. 6, pp. 513-522, 2008.
11. T. K. Rao, A. D. Nicastri, and E. A. Friedman, "Natural history of heroin-associated nephropathy," The New England Journal of Medicine, vol. 290, no. 1, pp. 19-23, 1974.
12. A. N. Bennett, P. Peterson, S. Sangle et al., "Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil," Rheumatology, vol. 43, no. 6, pp. 795-799, 2004.
13. T. Kofman, C. Narjoz, Q. Raimbourg et al., "Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation," Lupus, vol. 21, no. 13, pp. 1459-1462, 2012.
14. R. Gupta, A. Sharma, D. M. Bhowmik, S. Gupta, S. K. Agarwal, and A. K. Dinda, "Collapsing glomerulopathy occurring in HIV-negative patients with systemic lupus erythematosus: report of three cases and brief review of the literature," Lupus, vol. 20, no. 8, pp. 866-870, 2011.
15. M. Mubarak, "Collapsing focal segmental glomerulosclerosis: current concepts," World Journal of Nephrology, vol. 1, no. 2, pp. 35-42, 2012.
16. M. D. C. Avila-Casado, I. Perez-Torres, A. Auron, V. Soto, T. I. Fortoul, and J. Herrera-Acosta, "Proteinuria in rats induced by serum from patients with collapsing glomerulopathy," Kidney International, vol. 66, no. 1, pp. 133-143, 2004.
17. L. Barisoni, W. Kriz, P. Mundel, and V. D'Agati, "The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV- associated nephropathy," Journal of the American Society of Nephrology, vol. 10, no. 1, pp. 51-61, 1999.
18. C. P. Larsen, M. L. Beggs, M. Saeed, and P. D. Walker, "Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy," Journal of the American Society of Nephrology, vol. 24, no. 5, pp. 722-725, 2013.
19. M. Haas, "Collapsing glomerulopathy in systemic lupus erythematosus: an extreme form of lupus podocytopathy?" Clinical Journal of the American Society of Nephrology, vol. 7, no. 6, pp. 878-880, 2012.
20. A. Hamad and L. Balsam, "Fulminant acute nephrotic syndrome in a patient with idiopathic collapsing focal segmental glomerulosclerosis after a febrile illness," American Journal of Nephrology, vol. 21, no. 1, pp. 84-85, 2001.
21. L. P. J. Marques, G. G. L. C. Pacheco, L. S. Rioja, S. N. Nunes, S. T. Velone, and O. R. Santos, "Can systemic lupus erythematosus be the cause of collapsing glomerulopathy?" Lupus, vol. 14, no. 10, pp. 853-855, 2005.
22. L. Grcevska and M. Polenakovik, "Collapsing glomerulopathy: clinical characteristics and follow-up," The American Journal of Kidney Diseases, vol. 33, no. 4, pp. 652-657, 1999.
23. A. Laurinavicius and H. G. Rennke, "Collapsing glomerulopathy-a new pattern of renal injury," Seminars in Diagnostic Pathology, vol. 19, no. 3, pp. 106-115, 2002.
24. M. Albaqumi and L. Barisoni, "Current views on collapsing glomerulopathy," Journal of the American Society of Nephrology, vol. 19, no. 7, pp. 1276-1281, 2008.
25. J. A. Schwimmer, G. S. Markowitz, A. Valeri, and G. B. Appel, "Collapsing glomerulopathy," Seminars in Nephrology, vol. 23, no. 2, pp. 209-218, 2003.
26. M. J. Chun, S. M. Korbet, M. M. Schwartz, and E. J. Lewis, "Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants," Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2169-2177, 2004.
27. M. L. Artero, R. Sharma, V. J. Savin, and F. Vincenti, "Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis," American Journal of Kidney Diseases, vol. 23, no. 4, pp. 574-581, 1994.
28. D. Gherardi, V. D'Agati, T. T. Chu et al., "Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202," Journal of the American Society of Nephrology, vol. 15, no. 5, pp. 1212-1222, 2004.